September 30, 2023MarketScreener
Foresee Pharmaceuticals to Present Phase 1/2 Fanconi Anemia Clinical Study Design for its ALDH2 Activator FP-045 at the Fanconi Anemia Research Fund 2023 Scientific Symposium
(marketscreener.com) Foresee Pharmaceuticals announced that the company will present the clinical des... See more »